Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1998 1
1999 2
2000 3
2001 2
2002 2
2003 1
2004 2
2005 3
2006 6
2007 2
2008 4
2009 3
2010 5
2011 1
2012 2
2013 2
2014 2
2015 2
2016 1
2017 3
2018 3
2020 2
2021 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
[Imatinib and solid tumours].
Arifi S, El Sayadi H, Dufresne A, Ray-Coquard I, Fayette J, Méeus P, Ranchère D, Decouvelaere AV, Alberti L, Tabone-Eglinger S, Blay JY, Cassier P. Arifi S, et al. Among authors: ranchere d. Bull Cancer. 2008 Jan;95(1):99-106. doi: 10.1684/bdc.2008.0557. Bull Cancer. 2008. PMID: 18230575 Review. French.
[Soft tissue tumor with adipocytic differentiation].
Le Loarer F, Renard C, Ranchere D. Le Loarer F, et al. Among authors: ranchere d. Ann Pathol. 2020 Jul;40(4):263-268. doi: 10.1016/j.annpat.2020.02.012. Epub 2020 Apr 29. Ann Pathol. 2020. PMID: 32359934 French. No abstract available.
ET-743: a novel agent with activity in soft tissue sarcomas.
Fayette J, Coquard IR, Alberti L, Ranchère D, Boyle H, Blay JY. Fayette J, et al. Among authors: ranchere d. Oncologist. 2005 Nov-Dec;10(10):827-32. doi: 10.1634/theoncologist.10-10-827. Oncologist. 2005. PMID: 16314293 Free article. Review.
[Neoadjuvant chemotherapy in sarcoma].
Blay JY, Bonvalot S, Fayette J, Stockle E, Ray-Coquard I, Coindre JM, Duffaud F, Taieb S, Sunyach MP, Ranchere D, Meeus P, Le Cesne A, Bui BN. Blay JY, et al. Among authors: ranchere d. Bull Cancer. 2006 Nov;93(11):1093-8. Bull Cancer. 2006. PMID: 17145578 Free article. Review. French.
ET-743: a novel agent with activity in soft-tissue sarcomas.
Fayette J, Coquard IR, Alberti L, Boyle H, Méeus P, Decouvelaere AV, Thiesse P, Sunyach MP, Ranchère D, Blay JY. Fayette J, et al. Among authors: ranchere d. Curr Opin Oncol. 2006 Jul;18(4):347-53. doi: 10.1097/01.cco.0000228740.70379.3f. Curr Opin Oncol. 2006. PMID: 16721129 Review.
Imatinib mesilate for the treatment of gastrointestinal stromal tumour.
Cassier PA, Dufresne A, Arifi S, El Sayadi H, Labidi I, Ray-Coquard I, Tabone S, Méeus P, Ranchère D, Sunyach MP, Decouvelaere AV, Alberti L, Blay JY. Cassier PA, et al. Among authors: ranchere d. Expert Opin Pharmacother. 2008 May;9(7):1211-22. doi: 10.1517/14656566.9.7.1211. Expert Opin Pharmacother. 2008. PMID: 18422477 Review.
Emerging drugs for the treatment of soft tissue sarcomas.
Cassier PA, Dufresne A, Fayette J, Alberti L, Ranchere D, Ray-Coquard I, Blay JY. Cassier PA, et al. Among authors: ranchere d. Expert Opin Emerg Drugs. 2007 Mar;12(1):139-53. doi: 10.1517/14728214.12.1.139. Expert Opin Emerg Drugs. 2007. PMID: 17355219 Review.
Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network.
de Pinieux G, Karanian M, Le Loarer F, Le Guellec S, Chabaud S, Terrier P, Bouvier C, Batistella M, Neuville A, Robin YM, Emile JF, Moreau A, Larousserie F, Leroux A, Stock N, Lae M, Collin F, Weinbreck N, Aubert S, Mishellany F, Charon-Barra C, Croce S, Doucet L, Quintin-Rouet I, Chateau MC, Bazille C, Valo I, Chetaille B, Ortonne N, Brouchet A, Rochaix P, Demuret A, Ghnassia JP, Mescam L, Macagno N, Birtwisle-Peyrottes I, Delfour C, Angot E, Pommepuy I, Ranchere D, Chemin-Airiau C, Jean-Denis M, Fayet Y, Courrèges JB, Mesli N, Berchoud J, Toulmonde M, Italiano A, Le Cesne A, Penel N, Ducimetiere F, Gouin F, Coindre JM, Blay JY; NetSarc/RePPS/ResSos and French Sarcoma Group- Groupe d’Etude des Tumeurs Osseuses (GSF-GETO) networks. de Pinieux G, et al. Among authors: ranchere d. PLoS One. 2021 Feb 25;16(2):e0246958. doi: 10.1371/journal.pone.0246958. eCollection 2021. PLoS One. 2021. PMID: 33630918 Free PMC article.
SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type.
Andrianteranagna M, Cyrta J, Masliah-Planchon J, Nemes K, Corsia A, Leruste A, Holdhof D, Kordes U, Orbach D, Corradini N, Entz-Werle N, Pierron G, Castex MP, Brouchet A, Weingertner N, Ranchère D, Fréneaux P, Delattre O, Bush J, Leary A, Frühwald MC, Schüller U, Servant N, Bourdeaut F. Andrianteranagna M, et al. Among authors: ranchere d. J Pathol. 2021 Sep;255(1):1-15. doi: 10.1002/path.5705. Epub 2021 Jun 23. J Pathol. 2021. PMID: 33999421
55 results